Real-time enrollment status for this alpha-1 antitrypsin deficiency clinical trial
Current Status
Active, Not Recruiting
Checked: April 17, 2026 at 8:21 AM UTC
| NCT Number | NCT05897424 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Alpha-1 Antitrypsin Deficiency |
| Phase | Clinical Trial |
| Target Enrollment | 185 participants |
| Active Locations | 19 sites in the US |
| Sponsor | Sanofi |
| Last Updated on CT.gov | April 13, 2026 (4 days ago) |
As of April 17, 2026: Clinical trial NCT05897424 is currently active_not_recruiting participants. This clinical trial study for alpha-1 antitrypsin deficiency is not currently accepting new participants at 19 locations across the United States. The study is sponsored by Sanofi. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05897424 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 19 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05897424 was last updated 4 days ago (April 13, 2026). HelloStudys verifies this status automatically.